(lp0
S'XOMA CORPORATION  Files An 8-K Other Events Market Exclusive - 18 hours ago On March 21, 2017, XOMA Corporation  prepaid the full outstanding balance of approximately $6.5 million under the Loan and Security Agreement dated February 27, 2015, as amended by the Amendment No.'
p1
aS'XOMA Announces Full Repayment of Hercules Technology Growth Capital Debt ... GlobeNewswire  - 20 hours ago BERKELEY, Calif., March 22, 2017  -- XOMA Corporation , a pioneer in the discovery and development of therapeutic antibodies, announced today it has fully prepaid the outstanding balance of approximately $6.5&nbsp;...'
p2
aS'Buy XOMA Corporation For Its Monoclonal Antibodies To Treat Congenital ... Seeking Alpha - Jul 24, 2016 XOMA Corporation is an emerging biotechnology company with proprietary monoclonal antibody development technology that has attracted collaborations with large companies like Novartis and Novo Nordisk.'
p3
aS'XOMA Appoints Matthew Perry to its Board of Directors GlobeNewswire  - Feb 16, 2017 BERKELEY, Calif., Feb. 16, 2017  -- XOMA Corporation , a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Matthew Perry, President of BVF Partners L.P.'
p4
aS'XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from ... GlobeNewswire  - Dec 21, 2016 BERKELEY, Calif., Dec. 21, 2016  -- XOMA Corporation , a leader in the discovery and development of therapeutic antibodies, today announced several corporate actions to further streamline its operations to focus on&nbsp;...'
p5
aS"Xoma Corp Trading Well Above Recent Offering Price But Below October Reverse ... Benzinga - Feb 13, 2017 XOMA Corporation  shares are trading higher by $0.70  at $4.73 in Monday's session. The issue bottomed at its higher opening tick of $4.30 and has continued to move higher.XOMA Corporation  Stock: Gaining On Offering Pricing - CNA Finance XOMA Announces Pricing of $25 Million Registered Offering of Common Stock and ... - GlobeNewswire "
p6
aS"What is Behind XOMA Corporation's  Superior ROE? Simply Wall St - Mar 16, 2017 XOMA Corporation  delivered 35.4% ROE in the last year. However, to put XOMA's Return on Equity in perspective, we must compare it to the performance of its industry, which averaged an ROE of 27.46%.XOMA Corporation  To Release Earnings - UK Market News"
p7
aS"3 Things You Need to Know About XOMA Corp. Motley Fool - Mar 26, 2015 XOMA's product pipeline consists of human and humanized monoclonal antibodies designed to treat metabolic, inflammatory, and cardiovascular diseases."
p8
aS'XOMA Ltd: Odds Improving On This $1 Biotech Lottery Ticket Seeking Alpha - Oct 3, 2015 XOMA Corporation is a late-stage biotechnology company with expertise in allosteric modulation and a portfolio of innovative therapeutic monoclonal antibodies.'
p9
aS'Decision Time: XOMA Corporation  Stock Technicals Hit Inflection ... CML News - Mar 20, 2017 Decision Time: XOMA Corporation  now sits in the perhaps the most difficult technical position -- the stock has no urgency in its direction and that has left it at an inflection point.'
p10
a.